Price (90d)
$42.36Signal Score (90d)
80Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $5.36B | $-98.00M | $-0.43 |
| 2024 | $5.34B | $-664.00M | $-3.70 |
| 2023 | $5.34B | $-77.00M | $-0.37 |
| 2022 | $4.93B | $-63.00M | $-0.30 |
| 2021 | $3.70B | $-153.30M | $-0.73 |
Social Signal Score
Earnings
Wed, Nov 4(in 3 months)
Consensus estimate $-0.19 per share
Typical surprise -98.8% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Aug 5$-0.13 vs $-0.22beat
- Wed, May 6$-0.18 vs $-0.23beat
- Wed, Feb 25$0.03 vs $-0.08beat
- Wed, Nov 5$-0.44 vs $0.78miss
- Wed, Aug 6$-0.03 vs $0.75miss
- Wed, Apr 30$0.01 vs $0.82miss
Estimates and results for LINE via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
LINEhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Mentions (2)
- Newsmarketbeat.com·5d ago·Negative
Lineage Cell Therapeutics Q2 Earnings Call Highlights Lineage Cell Therapeutics NYSEAMERICAN: LCTX outlined progress across its cell-therapy pipeline during its second-quarter 2026 earnings call, highlighting preclinical advances in corneal disease, Type 1 diabetes and hearing loss programs while Roche and Genentech continue surgical-delivery optimization work for its lead OpRegen program.
View source ↗ - 4chan /biz/biz·7d ago·Neutral
>>62574447 Kakao Games Corp 5y -90% NCS' shares did double in value on release of Guild Wars 2, but 3x 9 years later with shit line Lineage Mobile.
View source ↗
